Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor
Crossref DOI link: https://doi.org/10.1007/s00262-017-2089-5
Published Online: 2017-11-10
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zuo, Bai-Le
Yan, Bo
Zheng, Guo-Xu
Xi, Wen-Jin
Zhang, Xiao
Yang, An-Gang
Jia, Lin-Tao
Funding for this research was provided by:
National Natural Sciences Foundation of China (No. 81630069, No. 81272646)
License valid from 2017-11-10